Skip to main content
. 2021 Sep 22;40:101127. doi: 10.1016/j.eclinm.2021.101127

Table 1.

Clinical outcomes and patient costs* for the clinical and economic review

Clinical outcomes for clinical review
Outcome category Outcome indicator
Sought Identified
Earlier diagnosis Disease severity at diagnosis - microbiology smear positivity among bacteriologically-confirmed TB patients; smear grade; Xpert cycle threshold values; culture grade/colonies; time to culture positivity smear positivity among bacteriologically-confirmed TB patients; smear grade
Disease severity at diagnosis - radiology CXR severity score/grading -
Disease severity at diagnosis - anthropometric body mass index -
Earlier diagnosis and
linkage to care
Time to first contact with health services duration from start of symptoms to first contact with health services duration from start of symptoms to first contact with health services
Time to diagnosis duration from start of symptoms to diagnosis duration from start of symptoms to diagnosis
Time to treatment start duration from start of symptoms to treatment start; time between diagnosis and treatment start duration from start of symptoms to treatment start; time between diagnosis and treatment start
Pre-treatment loss to follow-up lost to follow-up between diagnosis and treatment start lost to follow-up between diagnosis and treatment start
Treatment Treatment outcomes at treatment end treatment success (cure and completion); lost to follow-up treatment success (cure and completion); lost to follow-up
Disease outcome at treatment end - morbidity body mass index; lung function test results; TB recurrence -
Deaths Mortality among screened and unscreened groups all-cause mortality; TB-specific mortality all-cause mortality
Case fatality among diagnosed TB patients all-cause case fatality; TB-specific case fatality -
Case fatality among treated TB patients all-cause case fatality; TB-specific case fatality all-cause case fatality; TB-specific case fatality

Patient costs* for economic review
Outcome category Outcome - cost input

Pre-diagnosis Costs before TB diagnosis Direct medical - consultation/administration fees; drugs (TB, other); hospitalisation; laboratory investigations, radiology investigations, other investigations
Direct non-medical costs - transport, food, accommodation, nutritional supplements, childcare
Indirect - productivity loss
Diagnosis Costs during TB diagnosis
Pre-treatment Costs before TB treatment
May include pre-diagnosis and diagnosis costs
Treatment Costs during TB treatment
Entire illness period Costs during the illness period reported in the study
Catastrophic cost Prevalence proportion of total cost for TB care >20% of annual household income

*costs incurred by TB patients and their households